Finchley Healthcare Ventures
Montréal, Québec
Investment Thesis
Finchley Healthcare Ventures invests in emerging private companies developing novel therapies addressing significant unmet medical needs, with focus on last or second-to-last private financing rounds. Beyond capital, the fund leverages affiliation with Pharmascience Group to provide strategic support in drug development, manufacturing, regulatory affairs, and commercialization, supporting companies from proof-of-concept through clinical development across diverse modalities including small molecules, antibodies, and breakthrough technologies like nanotechnologies.
Focus Areas
Investment Stage
Growth
Sectors
Investment Signals
GeographyGlobal
ProvincesQC
Revenue Stagepre-revenue ok
Impact MandateYes
Business Modelsdeep-tech, IP-licensing
Sample Portfolio Companies
Capstan Therapeutics (acquired by AbbVie for $2.1B)
Cartography Biosciences
Reverb Therapeutics
Management Team
L
Leadership team with pharmaceuticals, VC, and financial management experience
What Makes Us Unique
Affiliation with Pharmascience providing strategic support and resources beyond capital.
AUM & Sources
Est. US$86M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.